MS vs CME
By Alex · Tickerpine
Morgan Stanley vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | CME |
|---|---|---|
| Price | $217.64 | $262.17 |
| Market cap | $342.13B | $94.27B |
| P/E ratio | 17.4 | 22.0 |
| ROE | 17.97% | 15.80% |
| Profit margin | 25.90% | 63.44% |
| Revenue growth | 28.00% | 0.80% |
| Dividend yield | 2.14% | 2.01% |
| Beta | 1.21 | 0.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs CME in plain English
- MS is the bigger company — about 3.6× the market cap of CME.
- MS is cheaper on earnings (P/E 17.4 vs 22.0).
- MS earns a higher return on equity (18% vs 16%).
- MS is growing revenue faster (28% vs 1%).
- MS has the higher dividend yield (2.14% vs 2.01%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.